The Human Phenotype Ontology (HPO) provides the following list of features that have been reported in people with this condition. Much of the information in the HPO comes from Orphanet, a European rare disease database. If available, the list includes a rough estimate of how common a feature is (its frequency). Frequencies are based on a specific study and may not be representative of all studies. You can use the MedlinePlus Medical Dictionary for definitions of the terms below.
|Signs and Symptoms||Approximate number of patients (when available)|
|Abnormality of the gastric mucosa||90%|
|Atypical scarring of skin||90%|
|Lack of skin elasticity||90%|
|Nausea and vomiting||90%|
|Skeletal muscle atrophy||90%|
|Abnormality of the myocardium||50%|
|Abnormality of the pericardium||50%|
|Feeding difficulties in infancy||50%|
|Telangiectasia of the skin||50%|
|Abnormal renal physiology||7.5%|
|Abnormal tendon morphology||7.5%|
|Coronary artery disease||7.5%|
|Abnormality of chromosome stability||-|
|Abnormality of the abdomen||-|
|Autosomal dominant inheritance||-|
Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.
Nonprofit support and advocacy groups bring together patients, families, medical professionals, and researchers. These groups often raise awareness, provide support, and develop patient-centered information. Many are the driving force behind research for better treatments and possible cures. They can direct people to research, resources, and services. Many groups also have experts who serve as medical advisors. Visit their website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
International Workshop on Scleroderma Research
Saturday, August 1, 2015 -
Wednesday, August 5, 2015
Location: Cambridge, United Kingdom
Description: The goals of this workshop are to provide for scientific interchange, promote collaboration and involve outstanding investigators in other fields. These scientific interactions with investigators traditionally outside of scleroderma (SSc) research are particularly important because SSc affects many different organ systems
Contact: James Witter, (301) 594-5032,firstname.lastname@example.org
Co-funding Institute(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases, Office of Rare Diseases Research
Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know. Submit a new question
If a mother has systemic sclerosis, would genetic testing be appropriate for her female children to guide in future childbearing decisions? See answer